Evidence map›Paper›PMID 39789855›Full record

SynthesisInfluenza and other respiratory viruses2025

Costs of Influenza Illness and Acute Respiratory Infections by Household Income Level: Catastrophic Health Expenditures and Implications for Health Equity.

Natalie Wodniak, Radhika Gharpure, Luzhao Feng, Xiaozhan Lai, Hai Fang, Jianmei Tian, Tao Zhang, Genming Zhao, Fernando Salcedo-Mejía, Nelson J Alvis-Zakzuk and 15 more

Abstract readSystematic Review
In one paragraph

Synthesis in Influenza and other respiratory viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Natalie WodniakInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0001-8963-4613
Radhika GharpureInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-0702-5628
Luzhao FengSchool of Population Medicine & Public Health, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Xiaozhan LaiDepartment of Health Policy and Management, School of Public Health, Peking University, Beijing, China.ORCID 0000-0001-8978-286X
Hai FangChina Center for Health Development Studies, Peking University, Beijing, China.
Jianmei TianChildren's Hospital of Soochow University, Suzhou, China.
Tao ZhangSchool of Public Health, Fudan University, Shanghai, China.
Genming ZhaoSchool of Public Health, Fudan University, Shanghai, China.ORCID 0000-0002-3160-809X
Fernando Salcedo-MejíaALZAK Foundation, Cartagena, Colombia.
Nelson J Alvis-ZakzukALZAK Foundation, Cartagena, Colombia.
Jorge JaraPan American Health Organization, Washington, DC, USA.
Fatimah DawoodInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Gideon O EmukuleInfluenza Division, Centers for Disease Control and Prevention, Nairobi, Kenya.
Linus K NdegwaInfluenza Division, Centers for Disease Control and Prevention, Nairobi, Kenya.
I-Ching SamDepartment of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.ORCID 0000-0002-1296-7898
Tsogt MendNational Influenza Center, National Center for Communicable Diseases, Ulaanbaatar, Mongolia.
Baigalmaa JantsansengeeNational Influenza Center, National Center for Communicable Diseases, Ulaanbaatar, Mongolia.
Stefano TempiaCenter for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.ORCID 0000-0003-4395-347X
Cheryl CohenCenter for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.ORCID 0000-0003-0376-2302
Sibongile WalazaCenter for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.ORCID 0000-0001-7588-2480
Wanitchaya KittikraisakInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-2295-4388
Arthorn RiewpaiboonMahidol University, Nakhon Pathom, Thailand.
Kathryn E LafondInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0001-5018-9591
Nelly MejiaGlobal Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
William W DavisInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0001-7062-9531

Funding

U.S. Centers for Disease Control and Prevention
6 · The paper itself

Abstract

backgroundSeasonal influenza illness and acute respiratory infections can impose a substantial economic burden in low- and middle-income countries (LMICs). We assessed the cost of influenza illness and acute respiratory infections across household income strata.

methodsWe conducted a secondary analysis of data from a prior systematic review of costs of influenza and other respiratory illnesses in LMICs and contacted authors to obtain data on cost of illness (COI) for laboratory-confirmed influenza-like illness and acute respiratory infection. We calculated the COI by household income strata and calculated the out-of-pocket (OOP) cost as a proportion of household income.

resultsWe included 11 studies representing 11 LMICs. OOP expenses, as a proportion of annual household income, were highest among the lowest income quintile in 10 of 11 studies: in 4/4 studies among the general population, in 6/7 studies among children, 2/2 studies among older adults, and in the sole study for adults with chronic medical conditions. COI was generally higher for hospitalizations compared with outpatient illnesses; median OOP costs for hospitalizations exceeded 10% of annual household income among the general population and children in Kenya, as well as for older adults and adults with chronic medical conditions in China.

conclusionsThe findings indicate that influenza and acute respiratory infections pose a considerable economic burden, particularly from hospitalizations, on the lowest income households in LMICs. Future evaluations could investigate specific drivers of COI in low-income household and identify interventions that may address these, including exploring household coping mechanisms. Cost-effectiveness analyses could incorporate health inequity analyses, in pursuit of health equity.

Indexed as

Cost of IllnessHealth EquityHealth ExpendituresIncomeInfluenza, HumanRespiratory Tract InfectionsDeveloping CountriesFamily CharacteristicsHospitalizationHumansacute respiratory infectioncatastrophic health expenditurecost of illnesshealth equityhousehold incomeinfluenza

Identifiers

PMID39789855
PMCPMC11718101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.